Exane Derivatives

SEC CIK: 0001623883
Latest filing: Jul 12, 2022

SEC filings (opens in a new tab)

MXCT holding history

Maxcyte, Inc. in every 13F filed by Exane Derivatives, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MXCT overview All 13F holders of MXCT Full Q2 2022 holdings

Shares (Q2 2022): 502
Value: $2.33K
% of portfolio: <0.1%
Quarters held: 3; Since Q3 2021

Holdings of MXCT by Exane Derivatives, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	502	$2.33K	<0.1%	+502	New	Holders
Q1 2022	0	$0	0.0%	−27,307−100.0%	Sold out	Holders
Q4 2021	27,307	$278.3K	0.1%	−6,365−18.9%	Reduced	Holders
Q3 2021	33,672	$411.1K	0.1%	+33,672	New	Holders